ArticleFrontiers in pain research (Lausanne, Switzerland)2023

Combining onabotulinumtoxin A with a CGRP antagonist for chronic migraine prophylaxis: where do we stand?

Lanfranco PellesiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.